
Cefscot S 500mg/250mg Injection
Marketer
Scotwin Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefscot S 500mg/250mg Injection
Cefscot S 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be solely by a medical professional. Consistent adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; escalating symptoms necessitate immediate medical attention. Seek urgent medical help for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Disclose all current medications to your physician prior to use. Pregnant or lactating individuals require medical consultation before commencement. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutritious food, and ample hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Cefscot S 500mg/250mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Cefscot S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefscot S 500mg/250mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefscot S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefscot S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefscot S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefscot S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefscot S 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefscot S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Cefscot S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefscot S 500mg/250mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cefscot S 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The injectable medication Cefscot S 500mg/250mg requires careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Cefscot S 500mg/250mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefscot S 500mg/250mg Injection :
Omit a Cefscot S 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Cefscot S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
